Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Medray Acquires Avista Medical
Medray, based in Dublin, Ireland, announced its acquisition of Avista Medical. According to data captured in the LevinPro HC database, this transaction represents the 34th healthcare product distributor transaction of 2023. Founded in 2004, Avista supplies medical imaging equipment and support services to radiology departments in hospitals. It is a support specialist for Canon Medical Systems, the global manufacturer of CT, MRI, X-Ray and Ultrasound diagnostic imaging equipment in Ireland. Medray supplies healthcare equipment to radiology, dental, veterinary and associated sectors across Ireland and the United Kingdom. The company was founded in 1979 and was bought by private... Read More »
Resurgens Technology Partners Acquires Valant Medical Solutions
Gemspring Capital, a private equity firm based in Westport, Connecticut, announced on December 4 the sale of Valant Medical Solutions to Resurgens Technology Partners. Aeris Partners served as financial advisor to Valant and McDermott Will & Emery LLP served as legal counsel to Gemspring. The financial terms were not disclosed. Valant Medical Solutions is a provider of SaaS-based electronic health record (EHR) and practice management software for behavioral health providers. It provides a comprehensive and differentiated software platform that enables customers to manage key operational, clinical and financial workflows to drive optimal business and patient outcomes. Valant... Read More »
New Mountain Capital-Backed PerkinElmer Acquires Covaris
PerkinElmer, backed by New York-based private equity firm New Mountain Capital, announced on December 4 that it has acquired Covaris. According to data in the LevinPro HC database, this transaction marks the 118th Laboratories, MRI and Dialysis acquisition of 2023, and 27th in the laboratories specialty. Covaris, also majority-owned by New Mountain Capital, provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations and manage compounds in the drug discovery process. The company was founded in 1999 in Woburn, Massachusetts. PerkinElmer provides products and services to the diagnostics, research, environmental, industrial and... Read More »
Roche Acquires Carmot Therapeutics for $2.7 Billion
Carmot Therapeutics Inc. announced on December 4 that it entered into a definitive merger agreement to be acquired by Roche Holding AG at a purchase price of $2.7 billion upfront and the potential for $400 million in milestone payments. Carmot Therapeutics is a biotechnology firm with injectable dual GLP-1/GIP receptor agonists and an oral GLP-1 drug in clinical development. The biotechnology company filed to go public in November 2023. Roche Holding AG, commonly known as Roche, operates in the pharmaceuticals and diagnostics businesses worldwide. The company’s headquarters are located in Basel, Switzerland. According to its 2022 annual report, Roche’s net sales... Read More »
Laborie Medical Technologies Invests in Start-Up Bright Uro
Laborie Medical Technologies Corp. (LMT) has announced a strategic equity investment in Bright Uro, an early-stage medical technology company headquartered in Irvine, California. Founded in 2021, Bright Uro is developing the Glean Urodynamic System™, a wireless, catheter-free, urodynamic monitoring system intended to quantify the pressure characteristics of the lower urinary tract. LMT, a subsidiary of Stockholm-based private equity firm Patricia Industries, is a global medical technology company focused on urology, urogynecology, gastroenterology, obstetrics, gynecology and neonatal health. LMT develops, manufactures and markets medical technology and consumables to diagnose and... Read More »
Quadrant-Backed Partnered Health Acquires New View Psychology
Partnered Health, a portfolio company of Quadrant Private Equity, has acquired a psychology services platform in a small but strategic bolt-on acquisition. The company announced its acquisition of New View Psychology (NVP) on November 30, 2023. Founded in 2005, NVP is an Australian business that connects organizations with psychologists. NVP acts as a bridge between its network of nearly 150 psychologists across the country and parties in need of their services, including GP clinics, corporates and Employee Assistance Program providers. Partnered Health is made up of a number of established businesses that have been delivering health services to more than five million people... Read More »
ReFocus Eye Health acquires Washington Eye Institute
ReFocus Eye Health announced that it has completed yet another transaction with the acquisition of Washington Eye Institute. Washington Eye Institute provides full-scope ophthalmologic care out of three locations in Maryland, spanning the Washington, D.C. MSA. According to its website, the practice has eight physicians on staff. ReFocus Eye Health, a portfolio company of investment firm Zenyth Partners, is an eye care management services organization that partners with more than 65 affiliated ophthalmologists and optometrists across 25 practice locations, and one ambulatory surgery center in the Northeast and Mid-Atlantic regions. This transaction is the seventh one to be... Read More »
Ampersand Capital Partners invests in Julius Clinical Research
Ampersand Capital Partners, based in Wellesley, Massachusetts, announced its acquisition of Julius Clinical Research. According to data captured in the LevinPro HC database, this acquisition is the 40th contract research organization (CRO) transaction of the year. Based in the Netherlands, Julius Clinical Research is a leading academic clinical CRO that provides clinical trial services and real-world evidence studies to biopharma sponsors. Founded in 1988, Ampersand is a middle-market private equity firm with more than $3 billion of assets under management dedicated to investments in the healthcare sector. This transaction will allow Julius Clinical Research to expand... Read More »
AbbVie Acquires ImmunoGen for $10.1 Billion, Expanding Solid Tumor Portfolio
AbbVie Inc. and ImmunoGen, Inc. announced on November 30 a definitive agreement under which AbbVie will acquire ImmunoGen, a publicly traded biotechnology company focused on the development of antibody-drug conjugate (ADC) technology to treat cancer. Under the terms of the transaction, AbbVie will acquire all outstanding shares of ImmunoGen for $31.26 per share in cash. The transaction values ImmunoGen at a total equity value of approximately $10.1 billion. ImmunoGen’s flagship cancer therapy ELAHERE® (mirvetuximab soravtansine-gynx) is approved for the treatment of platinum-resistant ovarian cancer. According to its 2022 financial report, ImmunoGen had total revenues of... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
